CIK 1773206
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 76.23% | 62 |
| Health Care Equipment & Supplies | 6.76% | 9 |
| Health Care Providers & Services | 6.55% | 6 |
| Insurance | 4.69% | 3 |
| Distributors | 3.02% | 1 |
| Unclassified | 1.35% | 2 |
| Food & Staples Retailing | 0.57% | 1 |
| Technology Hardware & Equipment | 0.52% | 1 |
| Life Sciences Tools & Services | 0.32% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | INSM | INSMED Inc | Health Care | 12.98% |
| 2 | RVMD | Revolution Medicines, Inc. | Health Care | 7.72% |
| 3 | CYTK | CYTOKINETICS INC | Health Care | 5.58% |
| 4 | REGN | REGENERON PHARMACEUTICALS, INC. | Health Care | 3.48% |
| 5 | VERA | Vera Therapeutics, Inc. | Health Care | 3.41% |
| 6 | CAH | CARDINAL HEALTH INC | Consumer Discretionary | 3.02% |
| 7 | ROIV | Roivant Sciences Ltd. | Health Care | 2.93% |
| 8 | BTSG | BrightSpring Health Services, Inc. | Health Care | 2.82% |
| 9 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Health Care | 2.76% |
| 10 | MRK | Merck & Co., Inc. | Health Care | 2.71% |
84/86 names classified · sector 98.6% of weight · industry 98.6% · mkt cap 91.6%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 98.6% of the book is sector-classified (unclassified names shown, never dropped).
Only 25% of book weight classified — the grid is NOT representative of the whole book.
Classified: 25.0% of book weight (22/86 names) · unclassified 75.0%: INSM, RVMD, CYTK, VERA, ROIV, RYTM, EWTX, AZN, ALHC, NVS +54 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | INSMINSMED INC | 1,500,000 | $245M | 13.0% | ADD 20% |
| 2 | RVMDREVOLUTION MEDICINES INC | 1,500,000 | $146M | 7.7% | ADD 25% |
| 3 | CYTKCYTOKINETICS INC | 1,600,000 | $105M | 5.6% | ADD 14% |
| 4 | REGNREGENERON PHARMACEUTICALS | 85,000 | $66M | 3.5% | TRIM −19% |
| 5 | VERAVERA THERAPEUTICS INC | 1,600,000 | $64M | 3.4% | TRIM −11% |
| 6 | CAHCARDINAL HEALTH INC | 270,000 | $57M | 3.0% | ADD 35% |
| 7 | ROIVROIVANT SCIENCES LTD | 2,000,000 | $55M | 2.9% | ADD 135% |
| 8 | BTSGBRIGHTSPRING HEALTH SVCS INC | 1,250,000 | $53M | 2.8% | ADD 67% |
| 9 | RYTMRHYTHM PHARMACEUTICALS INC | 600,000 | $52M | 2.8% | ADD 26% |
| 10 | MRKMERCK & CO INC | 425,000 | $51M | 2.7% | ADD 70% |
| 11 | EWTXEDGEWISE THERAPEUTICS INC | 1,600,000 | $50M | 2.7% | ADD 7% |
| 12 | AZNASTRAZENECA PLC | 250,000 | $49M | 2.6% | NEW |
| 13 | ALHCALIGNMENT HEALTHCARE INC | 2,575,000 | $45M | 2.4% | ADD 17% |
| 14 | NVSNOVARTIS AG | 250,000 | $38M | 2.0% | HOLD |
| 15 | BSXBOSTON SCIENTIFIC CORP | 550,000 | $35M | 1.8% | ADD 144% |
| 16 | LFSTLIFESTANCE HEALTH GROUP INC | 4,300,000 | $27M | 1.4% | ADD 43% |
| 17 | ASNDASCENDIS PHARMA A/S | 115,000 | $26M | 1.4% | ADD 28% |
| 18 | SRRKSCHOLAR ROCK HLDG CORP | 500,000 | $25M | 1.3% | ADD 67% |
| 19 | ELVELEVANCE HEALTH INC FORMERLY | 75,000 | $22M | 1.2% | ADD 25% |
| 20 | CNCCENTENE CORP DEL | 650,000 | $21M | 1.1% | HOLD |
| 21 | BBIOBRIDGEBIO PHARMA INC | 275,000 | $20M | 1.1% | NEW |
| 22 | MLYSMINERALYS THERAPEUTICS INC | 750,000 | $20M | 1.1% | HOLD |
| 23 | NBIXNEUROCRINE BIOSCIENCES INC | 150,000 | $20M | 1.0% | HOLD |
| 24 | GKOSGLAUKOS CORP | 175,000 | $19M | 1.0% | TRIM −46% |
| 25 | ARWRARROWHEAD PHARMACEUTICALS IN | 300,000 | $19M | 1.0% | ADD 200% |
| 26 | VRTXVERTEX PHARMACEUTICALS INC | 40,000 | $18M | 0.9% | NEW |
| 27 | ORICORIC PHARMACEUTICALS INC | 1,400,000 | $18M | 0.9% | ADD 17% |
| 28 | ALMSALUMIS INC | 800,000 | $18M | 0.9% | NEW |
| 29 | FMSFRESENIUS MED CARE AG&CO KGA | 775,000 | $17M | 0.9% | ADD 19% |
| 30 | ISRGINTUITIVE SURGICAL INC | 35,000 | $16M | 0.9% | TRIM −68% |
| 31 | QUREUNIQURE NV | 900,000 | $15M | 0.8% | HOLD |
| 32 | TARSTARSUS PHARMACEUTICALS INC | 200,000 | $14M | 0.7% | HOLD |
| 33 | GILDGILEAD SCIENCES INC | 100,000 | $14M | 0.7% | NEW |
| 34 | LLYELI LILLY & CO | 15,000 | $14M | 0.7% | TRIM −25% |
| 35 | EWEDWARDS LIFESCIENCES CORP | 170,000 | $14M | 0.7% | TRIM −48% |
| 36 | COGTCOGENT BIOSCIENCES INC | 350,000 | $13M | 0.7% | NEW |
| 37 | ELANELANCO ANIMAL HEALTH INC | 550,000 | $13M | 0.7% | ADD 120% |
| 38 | MDGLMADRIGAL PHARMACEUTICALS INC | 25,000 | $13M | 0.7% | NEW |
| 39 | PRAXPRAXIS PRECISION MEDICINES I | 40,000 | $13M | 0.7% | HOLD |
| 40 | DNTHDIANTHUS THERAPEUTICS INC | 150,000 | $13M | 0.7% | TRIM −45% |
| 41 | RGNXREGENXBIO INC | 1,500,000 | $13M | 0.7% | ADD 25% |
| 42 | DGXQUEST DIAGNOSTICS INC | 60,000 | $12M | 0.6% | TRIM −20% |
| 43 | XENEXENON PHARMACEUTICALS INC | 200,000 | $12M | 0.6% | NEW |
| 44 | ERASERASCA INC | 700,000 | $11M | 0.6% | NEW |
| 45 | ANROALTO NEUROSCIENCE INC | 500,000 | $11M | 0.6% | ADD 33% |
| 46 | BIIBBIOGEN INC | 60,000 | $11M | 0.6% | TRIM −40% |
| 47 | DXCMDEXCOM | 175,000 | $11M | 0.6% | TRIM −65% |
| 48 | SOLENO THERAPEUTICS INC | 325,000 | $11M | 0.6% | HOLD |
| 49 | IRONDISC MEDICINE INC | 170,000 | $11M | 0.6% | NEW |
| 50 | NRIXNURIX THERAPEUTICS INC | 700,000 | $11M | 0.6% | ADD 133% |
| 51 | CVSCVS HEALTH CORP | 150,000 | $11M | 0.6% | TRIM −70% |
| 52 | COOCOOPER COS INC | 150,000 | $11M | 0.6% | TRIM −54% |
| 53 | TMOTHERMO FISHER SCIENTIFIC INC | 20,000 | $10M | 0.5% | NEW |
| 54 | LIVNLIVANOVA PLC | 150,000 | $10M | 0.5% | NEW |
| 55 | LNTHLANTHEUS HLDGS INC | 125,000 | $9M | 0.5% | ADD 25% |
| 56 | TNGXTANGO THERAPEUTICS INC | 450,000 | $9M | 0.5% | ADD 125% |
| 57 | IONSIONIS PHARMACEUTICALS INC | 125,000 | $9M | 0.5% | NEW |
| 58 | SANASANA BIOTECHNOLOGY INC | 3,200,000 | $9M | 0.5% | ADD 7% |
| 59 | CELCCELCUITY INC | 80,000 | $9M | 0.5% | HOLD |
| 60 | TARAPROTARA THERAPEUTICS INC | 1,750,000 | $9M | 0.5% | TRIM −22% |
| 61 | NVSTENVISTA HOLDINGS CORPORATION | 350,000 | $9M | 0.5% | TRIM −30% |
| 62 | BHVNBIOHAVEN LTD | 1,000,000 | $8M | 0.4% | TRIM −33% |
| 63 | SNDXSYNDAX PHARMACEUTICALS INC | 350,000 | $8M | 0.4% | ADD 75% |
| 64 | VKTXVIKING THERAPEUTICS INC | 250,000 | $8M | 0.4% | ADD 150% |
| 65 | DFTXDEFINIUM THERAPEUTICS INC COM SHS | 400,000 | $8M | 0.4% | NEW |
| 66 | BEAMBEAM THERAPEUTICS INC | 300,000 | $7M | 0.4% | TRIM −45% |
| 67 | RZLTREZOLUTE INC | 2,000,000 | $6M | 0.3% | HOLD |
| 68 | CAPRCAPRICOR THERAPEUTICS INC | 200,000 | $6M | 0.3% | NEW |
| 69 | IQVIQVIA HLDGS INC | 35,000 | $6M | 0.3% | NEW |
| 70 | AXSMAXSOME THERAPEUTICS INC. | 35,000 | $6M | 0.3% | NEW |
| 71 | PTGXPROTAGONIST THERAPEUTICS INC | 50,000 | $5M | 0.3% | NEW |
| 72 | EVMNEVOMMUNE INC | 225,000 | $5M | 0.3% | ADD 80% |
| 73 | ACHCACADIA HEALTHCARE COMPANY IN | 200,000 | $5M | 0.2% | NEW |
| 74 | ZBHZIMMER BIOMET HOLDINGS INC | 50,000 | $5M | 0.2% | NEW |
| 75 | FBRXFORTE BIOSCIENCES INC | 150,000 | $4M | 0.2% | NEW |
| 76 | LBRXLB PHARMACEUTICALS INC | 150,000 | $4M | 0.2% | ADD 50% |
| 77 | SVRASAVARA INC | 600,000 | $3M | 0.2% | NEW |
| 78 | RLMDRELMADA THERAPEUTICS INC | 450,000 | $3M | 0.2% | NEW |
| 79 | IMCRIMMUNOCORE HLDGS PLC | 100,000 | $3M | 0.2% | NEW |
| 80 | MAZEMAZE THERAPEUTICS INC | 100,000 | $3M | 0.2% | HOLD |
| 81 | TENXTENAX THERAPEUTICS INC | 167,000 | $3M | 0.1% | HOLD |
| 82 | IKTINHIBIKASE THERAPEUTICS INC | 1,350,000 | $2M | 0.1% | TRIM −23% |
| 83 | OLMAOLEMA PHARMACEUTICALS INC | 150,000 | $2M | 0.1% | NEW |
| 84 | IVAINVENTIVA SA | 400,000 | $2M | 0.1% | NEW |
| 85 | SIONSIONNA THERAPEUTICS INC | 50,000 | $2M | 0.1% | NEW |
| 86 | UNCYUNICYCIVE THERAPEUTICS INC | 225,000 | $1M | 0.1% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| INSMINSMED INC | 1.6M | 1.6M | 1.6M | 1.6M | 1.3M | 1.5M | $245M |
| RVMDREVOLUTION MEDICINES INC | 550K | 250K | 325K | 400K | 1.2M | 1.5M | $146M |
| CYTKCYTOKINETICS INC | 1.0M | 1.1M | 1.0M | 1.4M | 1.4M | 1.6M | $105M |
| REGNREGENERON PHARMACEUTICALS | — | — | 50K | 50K | 105K | 85K | $66M |
| VERAVERA THERAPEUTICS INC | 1.1M | 1.1M | 1.1M | 1.7M | 1.8M | 1.6M | $64M |
| CAHCARDINAL HEALTH INC | 250K | — | 140K | 130K | 200K | 270K | $57M |
| ROIVROIVANT SCIENCES LTD | — | 600K | 600K | 750K | 850K | 2.0M | $55M |
| BTSGBRIGHTSPRING HEALTH SVCS INC | 950K | 775K | 1.3M | 1.1M | 750K | 1.3M | $53M |
| RYTMRHYTHM PHARMACEUTICALS INC | 150K | — | 120K | 220K | 475K | 600K | $52M |
| MRKMERCK & CO INC | 200K | — | — | — | 250K | 425K | $51M |
| EWTXEDGEWISE THERAPEUTICS INC | 550K | 675K | 1.0M | 1.5M | 1.5M | 1.6M | $50M |
| AZNASTRAZENECA PLC | — | — | — | — | — | 250K | $49M |
| ALHCALIGNMENT HEALTHCARE INC | 500K | 200K | 400K | 1.6M | 2.2M | 2.6M | $45M |
| NVSNOVARTIS AG | — | 250K | 200K | 200K | 250K | 250K | $38M |
| BSXBOSTON SCIENTIFIC CORP | 550K | 650K | 550K | 300K | 225K | 550K | $35M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
